Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L21 pseudogene 79 (RPL21P79)
- Target
- RPL21P79
- Molecular classification
- Other (processed pseudogene)
01
Overview
Ribosomal protein L21 pseudogene 79 (*RPL21P79*) is a processed pseudogene found in the human genome that shares sequence similarity with the functional ribosomal protein L21 gene but does not encode a functional protein. Pseudogenes arise via retrotransposition or duplication events; although their DNA sequence resembles that of protein-coding genes, they typically contain disablements that prevent expression or function[6]. RPL21P79 has no reported biological function, disease association, molecular interactions, or biomarker utility, and is not considered a therapeutic target in drug discovery or translational medicine[6][7].
- Other names
- RPL21_33_903100271188
02
Mechanism of action
None (no known mechanisms, as it does not produce a functional molecule)
03
Biological functions
None (pseudogene; does not encode a protein and does not have a known biological function)
04
Disease associations
None (not functional, not implicated in disease)
05
Safety considerations
None (no therapeutic relevance)
06
Interacting drugs
None (no drugs interact with pseudogenes)
07
Biomarkers
None (not known as a biomarker)
Beyond the preview
Go deeper on Ribosomal protein L21 pseudogene 79 (RPL21P79).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L21 pseudogene 79 (RPL21P79).